391 results on '"Loré, Karin"'
Search Results
2. Cellular and humoral response to SARS-CoV-2 vaccine BNT162b2 in adults with Chronic Kidney Disease G4/5.
3. Author Correction: Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
4. Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
5. Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19
6. Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques
7. Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses
8. Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID
9. Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans
10. Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman Primates
11. NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals
12. Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
13. Herpes zoster mRNA vaccine induces superior vaccine immunity over licensed vaccine in mice and rhesus macaques
14. Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant
15. Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy.
16. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
17. Single cell transcriptomics of primate sensory neurons identifies cell types associated with chronic pain
18. Dendritic Cell Interactions with HIV-1 Envelope Glycoprotein: Implications for Preventing Transmission
19. Phenotyping of Myeloid-Derived Suppressor Cells in Nonhuman Primates
20. Clonal Tracking of Rhesus Macaque Hematopoiesis Highlights a Distinct Lineage Origin for Natural Killer Cells
21. Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
22. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates
23. Progress in vaccine development for infectious diseases—a Keystone Symposia report
24. Neutrophils acquire the capacity for antigen presentation to memory CD4+ T cells in vitro and ex vivo
25. Cell targeting and immunostimulatory properties of a novel Fcγ-receptor independent agonistic anti-CD40 antibody in rhesus macaques
26. Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial
27. Design and evaluation of surface and adjuvant modified PLGA microspheres for uptake by dendritic cells to improve vaccine responses
28. A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses
29. Innate immune mechanisms of mRNA vaccines
30. Targeting Dendritic Cells for Improved HIV-1 Vaccines
31. Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
32. Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19
33. Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression
34. Imaging the early fate of mRNA vaccines
35. Adenovirus type-35 vectors block human CD4⁺ T-cell activation via CD46 ligation
36. Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity
37. Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
38. Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
39. Appearance of IgG to SARS-CoV-2 in saliva effectively indicates seroconversion in mRNA vaccinated immunocompromised individuals
40. SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses
41. Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response
42. Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination
43. Immunity to SARS‐CoV‐2 induced by infection or vaccination
44. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity
45. Dendritic Cell Interactions with HIV-1 Envelope Glycoprotein: Implications for Preventing Transmission
46. IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcγRIIa
47. Tissue Myeloid Cells in SIV-Infected Primates Acquire Viral DNA through Phagocytosis of Infected T Cells
48. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity
49. Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans
50. Recurrent Herpes Zoster Ophthalmicus in a Patient With a Novel Toll-Like Receptor 3 Variant Linked to Compromised Activation Capacity in Fibroblasts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.